APIXABAN VERSUS WARFARIN FOR PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE TRIAL
Publication
, Conference
Guimaraes, P; Alexander, J; Wojdyla, D; Thomas, L; Alings, M; Flaker, G; Al-Khatib, S; Hanna, M; Wallentin, L; Granger, C; Lopes, R
Published in: Journal of the American College of Cardiology
April 2016
Duke Scholars
Published In
Journal of the American College of Cardiology
DOI
ISSN
0735-1097
Publication Date
April 2016
Volume
67
Issue
13
Start / End Page
691 / 691
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Guimaraes, P., Alexander, J., Wojdyla, D., Thomas, L., Alings, M., Flaker, G., … Lopes, R. (2016). APIXABAN VERSUS WARFARIN FOR PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE TRIAL. In Journal of the American College of Cardiology (Vol. 67, pp. 691–691). Elsevier BV. https://doi.org/10.1016/s0735-1097(16)30692-1
Guimaraes, Patricia, John Alexander, Daniel Wojdyla, Laine Thomas, Marco Alings, Greg Flaker, Sana Al-Khatib, et al. “APIXABAN VERSUS WARFARIN FOR PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE TRIAL.” In Journal of the American College of Cardiology, 67:691–691. Elsevier BV, 2016. https://doi.org/10.1016/s0735-1097(16)30692-1.
Guimaraes P, Alexander J, Wojdyla D, Thomas L, Alings M, Flaker G, et al. APIXABAN VERSUS WARFARIN FOR PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE TRIAL. In: Journal of the American College of Cardiology. Elsevier BV; 2016. p. 691–691.
Guimaraes, Patricia, et al. “APIXABAN VERSUS WARFARIN FOR PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE TRIAL.” Journal of the American College of Cardiology, vol. 67, no. 13, Elsevier BV, 2016, pp. 691–691. Crossref, doi:10.1016/s0735-1097(16)30692-1.
Guimaraes P, Alexander J, Wojdyla D, Thomas L, Alings M, Flaker G, Al-Khatib S, Hanna M, Wallentin L, Granger C, Lopes R. APIXABAN VERSUS WARFARIN FOR PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE TRIAL. Journal of the American College of Cardiology. Elsevier BV; 2016. p. 691–691.
Published In
Journal of the American College of Cardiology
DOI
ISSN
0735-1097
Publication Date
April 2016
Volume
67
Issue
13
Start / End Page
691 / 691
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology